# A Study of the Impact of an Early Biopsy in Patients Treated With CellCept (Mycophenolate Mofetil) After Kidney Transplantation

> **NCT00817687** · PHASE4 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 66 (actual)

## Conditions studied

- Kidney Transplantation

## Interventions

- **DRUG:** mycophenolate mofetil [CellCept]
- **DRUG:** mycophenolate mofetil [CellCept]

## Key facts

- **NCT ID:** NCT00817687
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01
- **Primary completion:** 2012-01
- **Final completion:** 2012-01
- **Target enrollment:** 66 (ACTUAL)
- **Last updated:** 2012-07-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00817687

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00817687, "A Study of the Impact of an Early Biopsy in Patients Treated With CellCept (Mycophenolate Mofetil) After Kidney Transplantation". Retrieved via MORVS 2026-10-10 from https://api.morvs.ai/clinical/NCT00817687. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*